Literature DB >> 26053119

Association Between Thoracic Spinal Cord Gray Matter Atrophy and Disability in Multiple Sclerosis.

Regina Schlaeger1, Nico Papinutto2, Alyssa H Zhu2, Iryna V Lobach3, Carolyn J Bevan2, Monica Bucci2, Antonella Castellano2, Jeffrey M Gelfand2, Jennifer S Graves2, Ari J Green4, Kesshi M Jordan5, Anisha Keshavan5, Valentina Panara2, William A Stern2, H-Christian von Büdingen2, Emmanuelle Waubant2, Douglas S Goodin2, Bruce A C Cree2, Stephen L Hauser2, Roland G Henry6.   

Abstract

IMPORTANCE: In multiple sclerosis (MS), upper cervical cord gray matter (GM) atrophy correlates more strongly with disability than does brain or cord white matter (WM) atrophy. The corresponding relationships in the thoracic cord are unknown owing to technical difficulties in assessing GM and WM compartments by conventional magnetic resonance imaging techniques.
OBJECTIVES: To investigate the associations between MS disability and disease type with lower thoracic cord GM and WM areas using phase-sensitive inversion recovery magnetic resonance imaging at 3 T, as well as to compare these relationships with those obtained at upper cervical levels. DESIGN, SETTING, AND PARTICIPANTS: Between July 2013 and March 2014, a total of 142 patients with MS (aged 25-75 years; 86 women) and 20 healthy control individuals were included in this cross-sectional observational study conducted at an academic university hospital. MAIN OUTCOMES AND MEASURES: Total cord areas (TCAs), GM areas, and WM areas at the disc levels C2/C3, C3/C4, T8/9, and T9/10. Area differences between groups were assessed, with age and sex as covariates.
RESULTS: Patients with relapsing MS (RMS) had smaller thoracic cord GM areas than did age- and sex-matched control individuals (mean differences [coefficient of variation (COV)]: 0.98 mm2 [9.2%]; P = .003 at T8/T9 and 0.93 mm2 [8.0%]; P = .01 at T9/T10); however, there were no significant differences in either the WM area or TCA. Patients with progressive MS showed smaller GM areas (mean differences [COV]: 1.02 mm2 [10.6%]; P < .001 at T8/T9 and 1.37 mm2 [13.2%]; P < .001 at T9/T10) and TCAs (mean differences [COV]: 3.66 mm2 [9.0%]; P < .001 at T8/T9 and 3.04 mm2 [7.2%]; P = .004 at T9/T10) compared with patients with RMS. All measurements (GM, WM, and TCA) were inversely correlated with Expanded Disability Status Scale score. Thoracic cord GM areas were correlated with lower limb function. In multivariable models (which also included cord WM areas and T2 lesion number, brain WM volumes, brain T1 and fluid-attenuated inversion recovery lesion loads, age, sex, and disease duration), cervical cord GM areas had the strongest correlation with Expanded Disability Status Scale score followed by thoracic cord GM area and brain GM volume. CONCLUSIONS AND RELEVANCE: Thoracic cord GM atrophy can be detected in vivo in the absence of WM atrophy in RMS. This atrophy is more pronounced in progressive MS than RMS and correlates with disability and lower limb function. Our results indicate that remarkable cord GM atrophy is present at multiple cervical and lower thoracic levels and, therefore, may reflect widespread cord GM degeneration.

Entities:  

Mesh:

Year:  2015        PMID: 26053119      PMCID: PMC6002864          DOI: 10.1001/jamaneurol.2015.0993

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN: 2168-6149            Impact factor:   18.302


  43 in total

1.  Spinal cord neuronal pathology in multiple sclerosis.

Authors:  Christopher P Gilmore; Gabriele C DeLuca; Lars Bö; Trudy Owens; James Lowe; Margaret M Esiri; Nikos Evangelou
Journal:  Brain Pathol       Date:  2008-12-19       Impact factor: 6.508

2.  A pilot MRI study of white and grey matter involvement by multiple sclerosis spinal cord lesions.

Authors:  H Kearney; K A Miszkiel; M C Yiannakas; O Ciccarelli; D H Miller
Journal:  Mult Scler Relat Disord       Date:  2012-10-10       Impact factor: 4.339

3.  Trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis.

Authors:  Iñigo Gabilondo; Elena H Martínez-Lapiscina; Eloy Martínez-Heras; Elena Fraga-Pumar; Sara Llufriu; Santiago Ortiz; Santiago Bullich; Maria Sepulveda; Carles Falcon; Joan Berenguer; Albert Saiz; Bernardo Sanchez-Dalmau; Pablo Villoslada
Journal:  Ann Neurol       Date:  2014-01-02       Impact factor: 10.422

4.  Bidirectional trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis.

Authors:  L J Balk; M D Steenwijk; P Tewarie; M Daams; J Killestein; M P Wattjes; H Vrenken; F Barkhof; C H Polman; B M J Uitdehaag; A Petzold
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-06-27       Impact factor: 10.154

5.  Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement.

Authors:  Peter Kellman; Andrew E Arai; Elliot R McVeigh; Anthony H Aletras
Journal:  Magn Reson Med       Date:  2002-02       Impact factor: 4.668

6.  Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients.

Authors:  C Bjartmar; G Kidd; S Mörk; R Rudick; B D Trapp
Journal:  Ann Neurol       Date:  2000-12       Impact factor: 10.422

Review 7.  Exploring the origins of grey matter damage in multiple sclerosis.

Authors:  Massimiliano Calabrese; Roberta Magliozzi; Olga Ciccarelli; Jeroen J G Geurts; Richard Reynolds; Roland Martin
Journal:  Nat Rev Neurosci       Date:  2015-03       Impact factor: 34.870

8.  A 3T MR imaging investigation of the topography of whole spinal cord atrophy in multiple sclerosis.

Authors:  J P Klein; A Arora; M Neema; B C Healy; S Tauhid; D Goldberg-Zimring; C Chavarro-Nieto; J M Stankiewicz; A B Cohen; G J Buckle; M K Houtchens; A Ceccarelli; E Dell'Oglio; C R G Guttmann; D C Alsop; D B Hackney; R Bakshi
Journal:  AJNR Am J Neuroradiol       Date:  2011-04-28       Impact factor: 3.825

9.  Spinal cord atrophy and disability in multiple sclerosis over four years: application of a reproducible automated technique in monitoring disease progression in a cohort of the interferon beta-1a (Rebif) treatment trial.

Authors:  X Lin; C R Tench; B Turner; L D Blumhardt; C S Constantinescu
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-08       Impact factor: 10.154

10.  A better characterization of spinal cord damage in multiple sclerosis: a diffusional kurtosis imaging study.

Authors:  E Raz; M Bester; E E Sigmund; A Tabesh; J S Babb; H Jaggi; J Helpern; R J Mitnick; M Inglese
Journal:  AJNR Am J Neuroradiol       Date:  2013-04-11       Impact factor: 3.825

View more
  27 in total

Review 1.  The Role of Advanced Magnetic Resonance Imaging Techniques in Multiple Sclerosis Clinical Trials.

Authors:  Kedar R Mahajan; Daniel Ontaneda
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

2.  Correlations between cervical spinal cord magnetic resonance diffusion tensor and diffusion kurtosis imaging metrics and motor performance in patients with chronic ischemic brain lesions of the corticospinal tract.

Authors:  Valentina Panara; R Navarra; P A Mattei; E Piccirilli; V Bartoletti; A Uncini; M Caulo
Journal:  Neuroradiology       Date:  2018-12-05       Impact factor: 2.804

3.  Association of HLA Genetic Risk Burden With Disease Phenotypes in Multiple Sclerosis.

Authors:  Noriko Isobe; Anisha Keshavan; Pierre-Antoine Gourraud; Alyssa H Zhu; Esha Datta; Regina Schlaeger; Stacy J Caillier; Adam Santaniello; Antoine Lizée; Daniel S Himmelstein; Sergio E Baranzini; Jill Hollenbach; Bruce A C Cree; Stephen L Hauser; Jorge R Oksenberg; Roland G Henry
Journal:  JAMA Neurol       Date:  2016-07-01       Impact factor: 18.302

4.  MRI Atlas-Based Measurement of Spinal Cord Injury Predicts Outcome in Acute Flaccid Myelitis.

Authors:  D B McCoy; J F Talbott; Michael Wilson; M D Mamlouk; J Cohen-Adad; Mark Wilson; J Narvid
Journal:  AJNR Am J Neuroradiol       Date:  2016-12-15       Impact factor: 3.825

5.  SUMMIT (Serially Unified Multicenter Multiple Sclerosis Investigation): creating a repository of deeply phenotyped contemporary multiple sclerosis cohorts.

Authors:  Riley Bove; Tanuja Chitnis; Bruce Ac Cree; Mar Tintoré; Yvonne Naegelin; Bernard Mj Uitdehaag; Ludwig Kappos; Samia J Khoury; Xavier Montalban; Stephen L Hauser; Howard L Weiner
Journal:  Mult Scler       Date:  2017-08-29       Impact factor: 6.312

6.  Spinal cord microstructure integrating phase-sensitive inversion recovery and diffusional kurtosis imaging.

Authors:  V Panara; R Navarra; P A Mattei; E Piccirilli; A R Cotroneo; N Papinutto; R G Henry; A Uncini; M Caulo
Journal:  Neuroradiology       Date:  2017-07-04       Impact factor: 2.804

Review 7.  Future Brain and Spinal Cord Volumetric Imaging in the Clinic for Monitoring Treatment Response in MS.

Authors:  Tim Sinnecker; Cristina Granziera; Jens Wuerfel; Regina Schlaeger
Journal:  Curr Treat Options Neurol       Date:  2018-04-20       Impact factor: 3.598

8.  Force control during submaximal isometric contractions is associated with walking performance in persons with multiple sclerosis.

Authors:  Leah A Davis; Mohammed S Alenazy; Awad M Almuklass; Daniel F Feeney; Taian Vieira; Alberto Botter; Roger M Enoka
Journal:  J Neurophysiol       Date:  2020-04-29       Impact factor: 2.714

9.  Intersubject Variability and Normalization Strategies for Spinal Cord Total Cross-Sectional and Gray Matter Areas.

Authors:  Nico Papinutto; Carlo Asteggiano; Antje Bischof; Tristan J Gundel; Eduardo Caverzasi; William A Stern; Stefano Bastianello; Stephen L Hauser; Roland G Henry
Journal:  J Neuroimaging       Date:  2019-09-30       Impact factor: 2.486

Review 10.  Magnetic resonance imaging in immune-mediated myelopathies.

Authors:  M J Wendebourg; S Nagy; T Derfuss; K Parmar; R Schlaeger
Journal:  J Neurol       Date:  2019-01-29       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.